BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND BCR, FLJ16453, 613, ENSG00000186716, BCR1, D22S662, D22S11, CML, P11274, PHL, ALL AND Prognosis
61 results:

  • 1. Targeting FLT3-TAZ signaling to suppress drug resistance in blast phase chronic myeloid leukemia.
    Shin JE; Kim SH; Kong M; Kim HR; Yoon S; Kee KM; Kim JA; Kim DH; Park SY; Park JH; Kim H; No KT; Lee HW; Gee HY; Hong S; Guan KL; Roe JS; Lee H; Kim DW; Park HW
    Mol Cancer; 2023 Nov; 22(1):177. PubMed ID: 37932786
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Survival and neurological outcomes after stereotactic biopsy of diffuse intrinsic pontine glioma: a systematic review.
    Dalmage M; LoPresti MA; Sarkar P; Ranganathan S; Abdelmageed S; Pagadala M; Shlobin NA; Lam S; DeCuypere M
    J Neurosurg Pediatr; 2023 Dec; 32(6):665-672. PubMed ID: 37724839
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Cost‑Effectiveness of Lorlatinib in First-Line Treatment of Adult Patients with Anaplastic Lymphoma Kinase (ALK)‑Positive Non‑Small‑Cell Lung cancer in Sweden.
    Naik J; Beavers N; Nilsson FOL; Iadeluca L; Lowry C
    Appl Health Econ Health Policy; 2023 Jul; 21(4):661-672. PubMed ID: 37173513
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. [Prognostic factors for non-small cell lung cancer patients with central nervous system metastasis with positive driver genes].
    Li R; Zhang SR; Liu XF; Zhang JW; Zhao JY; Bai P; Zhang XC
    Zhonghua Yi Xue Za Zhi; 2023 Apr; 103(16):1202-1209. PubMed ID: 37087403
    [No Abstract]    [Full Text] [Related]  

  • 5. B-cell Lymphoma 6 (BCL6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric cancers.
    McLachlan T; Matthews WC; Jackson ER; Staudt DE; Douglas AM; Findlay IJ; Persson ML; Duchatel RJ; Mannan A; Germon ZP; Dun MD
    Mol Cancer Res; 2022 Dec; 20(12):1711-1723. PubMed ID: 36166198
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. MS4A6A is a new prognostic biomarker produced by macrophages in glioma patients.
    Zhang C; Liu H; Tan Y; Xu Y; Li Y; Tong S; Qiu S; Chen Q; Su Z; Tian D; Zhou W; Zhong C
    Front Immunol; 2022; 13():865020. PubMed ID: 36119086
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Prokineticins as a Prognostic Biomarker for Low-Grade Gliomas: A Study Based on The cancer Genome Atlas Data.
    Zhong J; Xiang D; Ma X
    Biomed Res Int; 2022; 2022():2309339. PubMed ID: 35845958
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. RHEB is a potential therapeutic target in T cell acute lymphoblastic leukemia.
    Pham LT; Peng H; Ueno M; Kohno S; Kasada A; Hosomichi K; Sato T; Kurayoshi K; Kobayashi M; Tadokoro Y; Kasahara A; Shoulkamy MI; Xiao B; Worley PF; Takahashi C; Tajima A; Hirao A
    Biochem Biophys Res Commun; 2022 Sep; 621():74-79. PubMed ID: 35810594
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Linear and Circular Long Non-Coding RNAs in Acute Lymphoblastic Leukemia: From Pathogenesis to Classification and Treatment.
    Maimaitiyiming Y; Ye L; Yang T; Yu W; Naranmandura H
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457264
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. The Use of Inhibitors of Tyrosine Kinase in Paediatric Haemato-Oncology-When and Why?
    Kaczmarska A; Śliwa P; Lejman M; Zawitkowska J
    Int J Mol Sci; 2021 Nov; 22(21):. PubMed ID: 34769519
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Compromised anti-tumor-immune features of myeloid cell components in chronic myeloid leukemia patients.
    Harada I; Sasaki H; Murakami K; Nishiyama A; Nakabayashi J; Ichino M; Miyazaki T; Kumagai K; Matsumoto K; Hagihara M; Kawase W; Tachibana T; Tanaka M; Saito T; Kanamori H; Fujita H; Fujisawa S; Nakajima H; Tamura T
    Sci Rep; 2021 Sep; 11(1):18046. PubMed ID: 34508131
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Predicting prognosis and IDH mutation status for patients with lower-grade gliomas using whole slide images.
    Jiang S; Zanazzi GJ; Hassanpour S
    Sci Rep; 2021 Aug; 11(1):16849. PubMed ID: 34413349
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. New genetic prognostic biomarkers in primary central nervous system lymphoma (PCNSL).
    Gomes Candido Reis D; Levy D; Lage LAPC; Culler HF; Rocha V; Bydlowski SP; Nogueira Zerbini MC; Pereira J
    Brain Behav; 2021 Apr; 11(4):e02061. PubMed ID: 33591648
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Radiation-Associated Glioblastoma after Prophylactic Cranial Irradiation in a Patient of ALL: Review of Literature and Report of a Rare Case.
    Biswas A; Kashyap L; Bakhshi S
    Pediatr Neurosurg; 2020; 55(6):409-417. PubMed ID: 33271550
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Does location matter? Characterisation of the anatomic locations, molecular profiles, and clinical features of gliomas.
    Mackintosh C; Butterfield R; Zhang N; Lorence J; Zlomanczuk P; Bendok BR; Zimmerman RS; Swanson K; Porter A; Mrugala MM
    Neurol Neurochir Pol; 2020; 54(5):456-465. PubMed ID: 32914406
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. The prognostic impact of lymph node metastasis in patients with non-small cell lung cancer and distant organ metastasis.
    Yang J; Peng A; Wang B; Gusdon AM; Sun X; Jiang G; Zhang P
    Clin Exp Metastasis; 2019 Oct; 36(5):457-466. PubMed ID: 31420766
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. cancer survival trends in Kuwait, 2000-2013: A population-based study.
    Alawadhi E; Al-Awadi A; Elbasmi A; Coleman MP; Allemani C
    Gulf J Oncolog; 2019 Jan; 1(29):39-52. PubMed ID: 30956195
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Outcome of Patients with Non-Small Cell Lung cancer and brain Metastases Treated with Checkpoint Inhibitors.
    Hendriks LEL; Henon C; Auclin E; Mezquita L; Ferrara R; Audigier-Valette C; Mazieres J; Lefebvre C; Rabeau A; Le Moulec S; Cousin S; Duchemann B; le Pechoux C; Botticella A; Ammari S; Gazzah A; Caramella C; Adam J; Lechapt E; Planchard D; De Ruysscher D; Dingemans AM; Besse B
    J Thorac Oncol; 2019 Jul; 14(7):1244-1254. PubMed ID: 30780002
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. High cortactin expression in B-cell acute lymphoblastic leukemia is associated with increased transendothelial migration and bone marrow relapse.
    Velázquez-Avila M; Balandrán JC; Ramírez-Ramírez D; Velázquez-Avila M; Sandoval A; Felipe-López A; Nava P; Alvarado-Moreno JA; Dozal D; Prieto-Chávez JL; Schaks M; Rottner K; Dorantes-Acosta E; López-Martínez B; Schnoor M; Pelayo R
    Leukemia; 2019 Jun; 33(6):1337-1348. PubMed ID: 30573781
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Primary CNS lymphoma patient-derived orthotopic xenograft model capture the biological and molecular characteristics of the disease.
    Pouzoulet F; Alentorn A; Royer-Perron L; Assayag F; Mokhtari K; Labiod D; Le Garff-Tavernier M; Daniau M; Menet E; Peyre M; Schnitzler A; Guegan J; Davi F; Hoang-Xuan K; Soussain C
    Blood Cells Mol Dis; 2019 Mar; 75():1-10. PubMed ID: 30502564
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 4.